Beckmann Britt-Maria, Kääb Stefan
Medizinische Klinik und Poliklinik I, Ludwig-Maximilians-Universität München, D-81377, München, Germany.
Herzschrittmacherther Elektrophysiol. 2012 Sep;23(3):161-6. doi: 10.1007/s00399-012-0230-x. Epub 2012 Sep 20.
Genetic testing already has a substantial impact in identifying hereditary arrhythmia syndromes after sudden death in young patients. This report provides information on current developments, available options and reasonable approaches in the clinical setting. In addition the limitations of genetic testing are discussed. Genetic testing is only useful for patients in the context of clinical findings interpreted by an experienced cardiogenetics team.
基因检测在年轻患者猝死之后识别遗传性心律失常综合征方面已经产生了重大影响。本报告提供了有关临床环境中当前进展、可用选项和合理方法的信息。此外,还讨论了基因检测的局限性。基因检测仅对由经验丰富的心脏遗传学团队根据临床发现进行解读的患者有用。